Form 4: Director Timothy Stonesifer Increases Insulet Stake

Insulet Corporation Director Timothy C. Stonesifer purchased 2,790 shares of common stock at $143.51 per share.

Summary

• Director Timothy C. Stonesifer acquired 2,790 shares of Insulet Corporation (PODD) common stock.
• The transaction occurred on June 3, 2026, at a price of $143.51 per share.
• Following this transaction, the director's total beneficial ownership increased to 9,041 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as director-level insider buying typically indicates confidence in the company's future prospects.

Positives

• Insider confidence is demonstrated by the director's open-market purchase of company stock.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable.

Industry Context

StockSavvy.ai notes that insider buying is generally viewed as a positive signal of management's belief in the long-term value of the company, particularly in the medical device sector where long-term growth is driven by innovation and market penetration.

Comparison to Industry Standards

• Insider purchases by board members are standard practice and often viewed as a sign of alignment with shareholder interests.

Stakeholder Impact

• Shareholders may view this as a positive indicator of internal confidence in the company's valuation.

Key Dates

Keywords

Insulet, PODD, Insider Trading, Form 4, Director Purchase